The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer

Epithelial ovarian cancer remains the deadliest gynecologic malignancy. Despite advances in treatment, new approaches are needed. Histone deacetylases (HDACs) are a family of enzymes that regulate gene expression by removing acetyl groups from lysine residues on histones and non-histone proteins. In...

Descripción completa

Detalles Bibliográficos
Autor principal: Khabele, Dineo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033132/
https://www.ncbi.nlm.nih.gov/pubmed/24904826
http://dx.doi.org/10.3389/fonc.2014.00111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033132/
https://www.ncbi.nlm.nih.gov/pubmed/24904826
http://dx.doi.org/10.3389/fonc.2014.00111

Ejemplares similares